These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18090435)

  • 1. Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals.
    Galasko DR; Graff-Radford N; May S; Hendrix S; Cottrell BA; Sagi SA; Mather G; Laughlin M; Zavitz KH; Swabb E; Golde TE; Murphy MP; Koo EH
    Alzheimer Dis Assoc Disord; 2007; 21(4):292-9. PubMed ID: 18090435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease.
    Aisen PS; Saumier D; Briand R; Laurin J; Gervais F; Tremblay P; Garceau D
    Neurology; 2006 Nov; 67(10):1757-63. PubMed ID: 17082468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, tolerability, and effects on plasma and cerebrospinal fluid amyloid-beta after inhibition of gamma-secretase.
    Siemers ER; Dean RA; Friedrich S; Ferguson-Sells L; Gonzales C; Farlow MR; May PC
    Clin Neuropharmacol; 2007; 30(6):317-25. PubMed ID: 18090456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo profiling of CHF5022 and CHF5074 Two beta-amyloid1-42 lowering agents.
    Imbimbo BP; Del Giudice E; Cenacchi V; Volta R; Villetti G; Facchinetti F; Riccardi B; Puccini P; Moretto N; Grassi F; Ottonello S; Leon A
    Pharmacol Res; 2007 Apr; 55(4):318-28. PubMed ID: 17292621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Abeta levels do not reflect brain Abeta levels.
    Freeman SH; Raju S; Hyman BT; Frosch MP; Irizarry MC
    J Neuropathol Exp Neurol; 2007 Apr; 66(4):264-71. PubMed ID: 17413317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and changes in plasma and cerebrospinal fluid amyloid beta after a single administration of an amyloid beta monoclonal antibody in subjects with Alzheimer disease.
    Siemers ER; Friedrich S; Dean RA; Gonzales CR; Farlow MR; Paul SM; Demattos RB
    Clin Neuropharmacol; 2010; 33(2):67-73. PubMed ID: 20375655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
    Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug evaluation: (R)-flurbiprofen--an enantiomer of flurbiprofen for the treatment of Alzheimer's disease.
    Geerts H
    IDrugs; 2007 Feb; 10(2):121-33. PubMed ID: 17285465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma amyloid beta protein 42 in non-demented persons aged 75 years: effects of concomitant medication and medial temporal lobe atrophy.
    Blasko I; Kemmler G; Krampla W; Jungwirth S; Wichart I; Jellinger K; Tragl KH; Fischer P
    Neurobiol Aging; 2005; 26(8):1135-43. PubMed ID: 15917096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion.
    Peretto I; Radaelli S; Parini C; Zandi M; Raveglia LF; Dondio G; Fontanella L; Misiano P; Bigogno C; Rizzi A; Riccardi B; Biscaioli M; Marchetti S; Puccini P; Catinella S; Rondelli I; Cenacchi V; Bolzoni PT; Caruso P; Villetti G; Facchinetti F; Del Giudice E; Moretto N; Imbimbo BP
    J Med Chem; 2005 Sep; 48(18):5705-20. PubMed ID: 16134939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two single-center, double-blind, randomized, placebo-controlled, phase I studies to investigate the tolerability and pharmacokinetics of CH-1504, an antifolate, in healthy male subjects.
    Mant T; Jurcevic S; Szakacs C; Adams L; Boland J; Hewitt LA
    Clin Ther; 2008 Jan; 30(1):131-42. PubMed ID: 18343249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of enantiomers of ibuprofen and flurbiprofen after oral administration.
    Suri A; Grundy BL; Derendorf H
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):1-8. PubMed ID: 9021434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of medications on plasma amyloid beta (Abeta) 42: longitudinal data from the VITA cohort.
    Blasko I; Jungwirth S; Jellinger K; Kemmler G; Krampla W; Weissgram S; Wichart I; Tragl KH; Hinterhuber H; Fischer P
    J Psychiatr Res; 2008 Sep; 42(11):946-55. PubMed ID: 18155247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of CHF5074 after short-term administration in healthy subjects.
    Imbimbo BP; Frigerio E; Breda M; Fiorentini F; Fernandez M; Sivilia S; Giardino L; Calzà L; Norris D; Casula D; Shenouda M
    Alzheimer Dis Assoc Disord; 2013; 27(3):278-86. PubMed ID: 22922591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective modulation of amyloid-beta peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Abeta levels.
    Abdul-Hay SO; Edirisinghe P; Thatcher GR
    J Neurochem; 2009 Nov; 111(3):683-95. PubMed ID: 19702658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of flurbiprofen on steady-state plasma lithium levels.
    Hughes BM; Small RE; Brink D; McKenzie ND
    Pharmacotherapy; 1997; 17(1):113-20. PubMed ID: 9017771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects.
    Christopher R; Covington P; Davenport M; Fleck P; Mekki QA; Wann ER; Karim A
    Clin Ther; 2008 Mar; 30(3):513-27. PubMed ID: 18405789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entecavir pharmacokinetics, safety, and tolerability after multiple ascending doses in healthy subjects.
    Yan JH; Bifano M; Olsen S; Smith RA; Zhang D; Grasela DM; LaCreta F
    J Clin Pharmacol; 2006 Nov; 46(11):1250-8. PubMed ID: 17050790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia: a double-blind, placebo-controlled study with six-month open-label extension.
    Tzimos A; Samokhvalov V; Kramer M; Ford L; Gassmann-Mayer C; Lim P; Eerdekens M
    Am J Geriatr Psychiatry; 2008 Jan; 16(1):31-43. PubMed ID: 18165460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.